Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A EBIT

Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A (HOVNP) currently reports a EBIT of $730M as of July 2026. That compares with $1B in the prior-year period — down 27.8% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's EBIT history and peer comparisons.

Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's EBIT decreased from $1B to $730M — a 27.8% year-over-year decrease (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's EBIT of $730M is lower than the Healthcare sector average of $23B. That is roughly 96.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A reported $730M in EBIT as of July 2026. That compares with $1B in the prior-year period — down 27.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $730M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A, and consider following HOVNP for alerts when major investors trade the stock.